Jeremy VisserJul 201 min readVIDEO: HS disease burden and costs continue to increase after diagnosisAccording to a new study, hidradenitis suppurativa (HS) comorbidity burden and healthcare resource utilizations costs continue to increase after diagnosis.
According to a new study, hidradenitis suppurativa (HS) comorbidity burden and healthcare resource utilizations costs continue to increase after diagnosis.